Maryland State Retirement & Pension System Xencor Inc Transaction History

Maryland State Retirement & Pension System

  • $4.65 Billion
  • Q3 2024

A detailed history of Maryland State Retirement & Pension System transactions in Xencor Inc stock. As of the latest transaction made, Maryland State Retirement & Pension System holds 20,881 shares of XNCR stock, worth $534,553. This represents 0.01% of its overall portfolio holdings.

Number of Shares
20,881
Previous 21,499 2.87%
Holding current value
$534,553
Previous $406,000 3.2%
% of portfolio
0.01%
Previous 0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$15.7 - $21.65 $9,702 - $13,379
-618 Reduced 2.87%
20,881 $419,000
Q2 2024

Jul 30, 2024
SELL
$18.21 - $24.5 $7,957 - $10,706
-437 Reduced 1.99%
21,499 $406,000
Q1 2024

Apr 19, 2024
SELL
$18.65 - $26.52 $7,273 - $10,342
-390 Reduced 1.75%
21,936 $485,000
Q3 2023

Oct 23, 2023
SELL
$20.08 - $25.39 $24,136 - $30,518
-1,202 Reduced 5.11%
22,326 $449,000
Q2 2023

Jul 10, 2023
SELL
$24.77 - $29.9 $14,961 - $18,059
-604 Reduced 2.5%
23,528 $587,000
Q1 2023

Apr 20, 2023
SELL
$25.95 - $36.95 $11,521 - $16,405
-444 Reduced 1.81%
24,132 $673,000
Q4 2022

Jan 17, 2023
BUY
$24.79 - $30.86 $609,239 - $758,415
24,576 New
24,576 $0
Q2 2022

Aug 01, 2022
BUY
$19.74 - $29.01 $5,191 - $7,629
263 Added 1.11%
23,918 $655,000
Q1 2022

Apr 11, 2022
BUY
$26.68 - $41.63 $9,071 - $14,154
340 Added 1.46%
23,655 $631,000
Q4 2021

Feb 09, 2022
BUY
$33.67 - $43.44 $12,323 - $15,899
366 Added 1.59%
23,315 $935,000
Q3 2021

Oct 29, 2021
BUY
$30.65 - $35.68 $703,386 - $818,820
22,949 New
22,949 $755,000

Others Institutions Holding XNCR

# of Institutions
216
Shares Held
71.8M
Call Options Held
2.5K
Put Options Held
7.9K
View Full List

About Xencor Inc

XNCR Quotes by TradingView
  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.53B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Maryland State Retirement & Pension System Portfolio

Follow Maryland State Retirement & Pension System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maryland State Retirement & Pension System, based on Form 13F filings with the SEC.

News

Stay updated on Maryland State Retirement & Pension System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email